Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

机译：细胞免疫疗法作为维持疗法可延长小细胞肺癌患者的生存期

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSmall cell lung cancer (SCLC) relapses rapidly after the initial response to chemotherapy and shows drug-resistance. This study was to investigate the efficacy and safety of cellular immunotherapy (CIT) with autologous natural killer (NK), γδT, and cytokine-induced killer (CIK) cells as maintenance therapy for SCLC patients.

机译：背景小细胞肺癌（SCLC）在对化疗的最初反应后迅速复发，并显示出耐药性。这项研究旨在探讨自体自然杀伤（NK），γδT和细胞因子诱导的杀伤（CIK）细胞作为SCLC患者维持治疗的细胞免疫疗法（CIT）的有效性和安全性。

著录项

期刊名称 Journal of Translational Medicine
作者
Xiao Ding; He Cao; Xiao Chen; Haofan Jin; Ziling Liu; Guanjun Wang; Lu Cai; Dan Li; Chao Niu; Huimin Tian; Lei Yang; Yuguang Zhao; Wei Li; Jiuwei Cui;
展开▼
作者单位

展开▼
年(卷),期 2015(13),-1
年度 2015
页码 158
总页数 12
原文格式 PDF
正文语种
中图分类医学史;
关键词
Small cell lung cancer Cellular immunotherapy Maintenance therapy;

机译：小细胞肺癌;细胞免疫疗法;维持疗法;
入库时间 2022-08-21 10:49:55

相似文献

外文文献
中文文献
专利

1. Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer [J] . Xiao Ding, He Cao, Xiao Chen, Journal of Translational Medicine . 2015,第1期

机译：细胞免疫疗法作为维持疗法可延长小细胞肺癌患者的生存期
2. Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP) [J] . Alejandro Ruiz‐Pati?o, Oscar Arrieta, Andrés F. Cardona, Thoracic cancer. . 2020,第2期

机译：与化疗（Quijote-Clicap）相比，任何治疗患者的免疫疗法改善了先进的转移性非小细胞肺癌（NSCLC）的存活率
3. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy [J] . Martina Vrankar, Karmen Stanic Radiology and Oncology . 2018,第3期

机译：放化疗治疗局部晚期III期非小细胞肺癌患者的长期生存及免疫治疗的前景
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. Effect of Antibiotics on Immunotherapy Response in Patients with Non-small Cell Lung Cancer [D] . Esmail, Fatema M. 2019

机译：抗生素对非小细胞肺癌患者免疫疗法反应的影响
6. Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer [O] . Yan Xu, Zheng Xiang, Mohammed Alnaggar, 2021

机译：同种异体vγ9vδ2T细胞免疫疗法表现出有前途的临床安全性延长了晚期肺或肝癌患者的存活
7. Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer in extensive stage [O] . Ding Xiao, Cao He, Chen Xiao, 2016

机译：细胞免疫疗法作为维持疗法可延长小细胞肺癌患者广泛生存期

Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅